Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures

Epilepsy Research

Volumn 41, Issue 3, 2000, Pages 205-211

  Peltola, J ^a,b   Palmio, J ^a   Korhonen, L ^c   Suhonen, J ^a   Miettinen, A ^a   Hurme, M ^b   Lindholm, D ^c   Keranen T ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c Department of Neuroscience ^*  (Sweden)

Author keywords

Cytokines; Growth factors; Interleukin 1 receptor antagonist; Interleukin 6; Seizures

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; GRAND MAL EPILEPSY; HUMAN; LUMBAR PUNCTURE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD-BRAIN BARRIER; EPILEPSY, TONIC-CLONIC; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034308079     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(00)00140-6     Document Type: Article

References (31)

1. Akoev G.N., Chalisove N.I., Ludino M.I. et al. Epileptiform activity increases the level of nerve growth factor in cerebrospinal fluid of epileptic patients and in hippocampal neurons in tissue culture. Neuroscience. 75:1996;601-605.
2. Arend W.P., Malyak M., Guthridge C.J., Gabay C. Interleukin-1 receptor antagonist: role in biology. Ann. Rev. Immunol. 16:1998;27-55.
3. Banks W., Kastin A., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179:1994;53-56.
4. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin 6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37:1995;800-804.
5. Eriksson C., Winblad B., Schultzberg M. Kainic acid induced the expression of interleukin-1 receptor antagonist mRNA in the rat brain. Mol. Brain Res. 58:1998;195-208.
6. Gall C. Seizure induced changes in neurotrophin expression- implications for epilepsy. Exp. Neurol. 124:1993;150-166.
7. Gruol D.L., Nelson T.E. Physiologlcal and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:1997;3307-3339.
8. Gutierrez E.G., Banks W.A.S., Kastin A.J. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J. Neurolmmunol. 55:1994;153-160.
9. Ichiyama T., Nishikawa M., Yoshitomi T., Hayashi T., Furukawa S. Tumor necrosis factor-a, interleukin-1, and interleukin-6 in cerebrospinal fluid from children with prolonged febrile seizures. Neurology. 50:1998;407-411.
10. Kiefer R., Lindholm D., Kreutzberg G.M. Interleukin-6 and transforming growth factor-β1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci. 5:1993;775-781.
11. Kossman T., Hans V., Imhof H.G., Trentz O., Morganti-Kossman M.C. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 7131:1996;143-152.
12. Lahat E., Livine M., Barr J., Katz Y. Interleukin-1 levels in serum and cerebrospinal fluid of children with febrile seizures. Pediatr. Neurol. 17:1997;34-36.
13. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 110:1998;1188-1195.
14. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 3:1987;658-659.
15. Lindholm D. Regulation of neurotrophic factor synthesis in CNS by various cytokines. J. Neurochem. 40:1992;130.
16. McClain C., Cohen D., Phillips R., Ott L., Young B. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. 118:1991;1.
17. Minami M., Kuraishi Y., Yamaguchi T. et al. Convulsants induce interleukin-1β messenger RNA in rat brain. Blochem. Biophys. Res. Commun. 171:1990;832-837.
18. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1α, IL-6, TNFα and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
19. Nishiyori A., Minami M., Satoh M. Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Mol. Brain Res. 501:1997;237-245.
20. Olsson T. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur. J. Neurol. 1:1994;7-19.
21. Panegyres P.K., Hughes J. The neuroprotective effects of the recombmant interleukin-1 receptor antagonist after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. J. Neurol. Sci. 154:1998;123-132.
22. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31:1998;129-133.
23. Qiu Z., Sweeney D.D., Netzeband J., Gruol D.L. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicit developing CNS neurons. J. Neurosci. 1:1998;10445-10456.
24. Riikonen R., Soderstrom S., Vanhala R., Ebendal T., Lindholm D. West'syndrome - cerebrospinal fluid NGF and effect of ACTH. Pediatric. Neurol. 17:1997;224-229.
25. Schneider H., Pitossi F., Balschun D., Wagner A., Del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin 1 in the hippocampus. Proc. Natl. Acad. Sci. 95:1998;7778-7783.
26. Ruth R.E. Increased cerebrovascular permeability to protein during systemic kainic acid seizures. Epilepsia. 25:1984;259-268.
27. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., Mier J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 83:1994;113-211.
28. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.
29. Yong V.W. Cytokines, astrogliosis, and neurotrophism following CNS trauma. Ransohoff R.M., Benveniste E.N. Cytokines and the CNS. 1996;309-327 Boca Raton, CRC Press.
30. Waage A., Halstensen A., Shalaby R. et al. Local production of tumor necrosis factor ct, interleukin 1 and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170:1989;1859-1867.
31. Zafra F., Hengerer B., Leibrock J., Thoenen R., Lindholm D. Activity-dependent regulation of BDNF and NGF mRNA in the rat hippocampus is mediated by nonNXMA glutamate receptor. EMBO. 9:1990;545-3550.